Grepafloxacin: a review of its safety profile based on clinical trials and postmarketing surveillance.

MLA

Lode, H., et al. “Grepafloxacin: A Review of Its Safety Profile Based on Clinical Trials and Postmarketing Surveillance.” Clinical Therapeutics, vol. 21, no. 1, Jan. 1999, pp. 61–74. EBSCOhost, https://doi.org/10.1016/S0149-2918(00)88268-5.

APA

Lode, H., Vogel, F., & Elies, W. (1999). Grepafloxacin: a review of its safety profile based on clinical trials and postmarketing surveillance. Clinical Therapeutics, 21(1), 61–74. https://doi.org/10.1016/S0149-2918(00)88268-5

Chicago

Lode, H, F Vogel, and W Elies. 1999. “Grepafloxacin: A Review of Its Safety Profile Based on Clinical Trials and Postmarketing Surveillance.” Clinical Therapeutics 21 (1): 61–74. doi:10.1016/S0149-2918(00)88268-5.